Modulight Biotherapeutics
PrivateLast Round
Seed
Nov 12, 2025
Total Funding Raised
$12.2M
Company Overview
Modulight Biotherapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in November 2025.
Modulight Biotherapeutics is a biotechnology company developing a precision neuromodulation platform using optogenetics to treat severe neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulight Biotherapeutics Comparables
Compare Modulight Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Opsin Biotherapeutics | 81% | |
| Kriya Therapeutics | 74% | |
| Circuit Therapeutics, Inc. | 74% |
For institutional investors. Book with your work email.
Modulight Biotherapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Modulight Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Fresh.Fund | Seed |
| Jibe Ventures | Seed |
| Nexus NeuroTech Ventures | Seed |
| Secret Chord Ventures | Seed |
| Phoenix Court Group | Seed |
| SilverArc Capital Management | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 32% MoM, reaching 2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 5, 2026
Modulight Biotherapeutics is developing a treatment that suppresses pain signals targeting facial nerves, which can cause severe chronic pain when damaged or irritated, in the United States.
For institutional investors. Book with your work email.
Modulight Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Modulight Biotherapeutics's valuation, stock price, and market status.
Is Modulight Biotherapeutics a public or private company?
Modulight Biotherapeutics is a private company.
What is the current stock price of Modulight Biotherapeutics?
Modulight Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Modulight Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Modulight Biotherapeutics worth (valuation)?
Valuation information for Modulight Biotherapeutics is not publicly available.
Can I buy Modulight Biotherapeutics stock?
Modulight Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Modulight Biotherapeutics's last funding round?
Modulight Biotherapeutics's most recent funding round was Seed on November 12, 2025.
Who are the main investors in Modulight Biotherapeutics?
Key investors in Modulight Biotherapeutics include Jibe Ventures, Phoenix Court Group, LocalGlobe.
Will Modulight Biotherapeutics IPO soon?
No public IPO plans have been announced for Modulight Biotherapeutics.
How can I track Modulight Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Modulight Biotherapeutics's shares on secondary markets.